Human Microbiome Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Human Microbiome Market to 2025 - Global Analysis and Forecasts By Product (Foods, Medical Foods, Probiotics, Prebiotics, Drugs, Diagnostic Devices, and Other Probiotic Supplements), By Disease (Diabetes, Cancer, Autoimmune Disorders, Obesity, Mental Disorders and Others), By Application (Diagnostics and Therapeutics), and By Geography

Report Code: TIPBT00002233 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
A microbiome is a genetic material of a wide collection of microbes that located in skin. Rheumatoid arthritis, diabetes, fibromyalgia, multiple sclerosis and muscular dystrophy are autoimmune diseases that associated with dysfunction in the microbiome. The microbes including bacteria, fungi and viruses, can be frequently isolated from patients with acute or chronic infections. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body. The human microbiome help to digest the food, regulate the immune system and protect the body from these foreign bacteria. Moreover, the human microbiome helps to produce the vitamins including vitamin K, vitamins B & vitamins B12 and thiamine & riboflavin. The human microbiome is essential for the growth, immunity and metabolic process such as vitamin synthesis, food digestion and brain function.

The market of human microbiome is anticipated to grow with a significant rate in the forecast period, owing to factors including increased focus on human microbiome therapy, rising aging population, increasing incidences of lifestyle diseases, and participation with leading health institutions is the primary factor which is driving the growth of human microbiome market. On other hand, the increasing collaboration activities are expected to likely to add novel opportunities for the players that are operating in the human microbiome market.

The "Global Human Microbiome Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global human microbiome market with detailed market segmentation by product, disease, application and geography. The global human microbiome market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global human microbiome market is segmented on the basis of product, disease and application. The product segment includes medical foods, probiotics, foods, prebiotics, drugs, diagnostic devices and other probiotic supplements. On the basis of application, the human microbiome market is classified as diagnostics, and therapeutics segments. Based on the disease, the human microbiome market is categorized into diabetes, cancer, autoimmune disorders, obesity, mental disorders and other diseases.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global human microbiome market based on product, disease and application. It also provides market size and forecast till 2025 for overall human microbiome market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

Europe region will anticipated to capture largest market share of human microbiome market within the forecast period, owing to the high acceptance of probiotic and prebiotic products, rising prevalence of communicable diseases, and Europe's aging population size, growing awareness among patients regarding the use of microbiome-based products are drive the market in Europe. However, the Asia-Pacific region is expected to register high-growth rates during the forecast period, with the majority of growth primarily driven by owing to the increasing incidences of cardiac diseases, diabetes and obesity and growing awareness among consumers regarding the favorable benefits of the microbiome are expected to contribute to the growth of the human microbiome market.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key human microbiome manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the human microbiome market including ENTEROME, Merck & Co., Inc., MICROBIOME THERAPEUTICS, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DUPONT and among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. HUMAN MICROBIOME MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Human Microbiome Market - By Product
3.2.2. Human Microbiome Market - By Disease
3.2.3. Human Microbiome Market - By Application
3.2.4. Human Microbiome Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. HUMAN MICROBIOME MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. CLINICAL TRIALS
4.5. IMPACT ANALYSIS

5. HUMAN MICROBIOME MARKET - GLOBAL ANALYSIS
5.1. GLOBAL HUMAN MICROBIOME MARKET OVERVIEW
5.2. GLOBAL HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS

6. HUMAN MICROBIOME MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA

7. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. FOODS MARKET
7.3.1. Overview
7.3.2. Foods Market Revenue Forecasts and Analysis (US$ Mn)
7.4. MEDICAL FOODS MARKET
7.4.1. Overview
7.4.2. Medical Foods Market Revenue Forecasts and Analysis (US$ Mn)
7.5. PROBIOTICS MARKET
7.5.1. Overview
7.5.2. Probiotics Market Revenue Forecasts and Analysis (US$ Mn)
7.6. PREBIOTICS MARKET
7.6.1. Overview
7.6.2. Prebiotics Market Revenue Forecasts and Analysis (US$ Mn)
7.7. DRUGS MARKET
7.7.1. Overview
7.7.2. Drugs Market Revenue Forecasts and Analysis (US$ Mn)
7.8. DIAGNOSTIC DEVICES MARKET
7.8.1. Overview
7.8.2. Diagnostic Devices Market Revenue Forecasts and Analysis (US$ Mn)
7.9. OTHER PROBIOTIC SUPPLEMENTS MARKET
7.9.1. Overview
7.9.2. Other Probiotic Supplements Market Revenue Forecasts and Analysis (US$ Mn)

8. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. DIABETES MARKET
8.3.1. Overview
8.3.2. Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CANCER MARKET
8.4.1. Overview
8.4.2. Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.5. AUTOIMMUNE DISORDERS MARKET
8.5.1. Overview
8.5.2. Autoimmune Disorders Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OBESITY MARKET
8.6.1. Overview
8.6.2. Obesity Market Revenue Forecasts and Analysis (US$ Mn
8.7. MENTAL DISORDERS MARKET
8.7.1. Overview
8.7.2. Mental Disorders Market Revenue Forecasts and Analysis (US$ Mn
8.8. OTHER DISEASES MARKET
8.8.1. Overview
8.8.2. Other Diseases Market Revenue Forecasts and Analysis (US$ Mn)
9. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. DIAGNOSTICS MARKET
9.3.1. Overview
9.3.2. Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
9.4. THERAPEUTICS MARKET
9.4.1. Overview
9.4.2. Therapeutics Market Revenue Forecasts and Analysis (US$ Mn)

10. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. NORTH AMERICA HUMAN MICROBIOME MARKET OVERVIEW
10.2. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
10.5. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.6. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

10.7. US MARKET OVERVIEW
10.7.1. US Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. US Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.7.3. US Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. CANADA MARKET OVERVIEW
10.8.1. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.8.3. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9. MEXICO MARKET OVERVIEW
10.9.1. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.2. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.9.3. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

11. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. EUROPE HUMAN MICROBIOME MARKET OVERVIEW
11.2. EUROPE HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
11.5. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.6. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

11.7. UK MARKET OVERVIEW
11.7.1. UK Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. UK Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.7.3. UK Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. GERMANY MARKET OVERVIEW
11.8.1. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.8.3. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9. FRANCE MARKET OVERVIEW
11.9.1. France Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.2. France Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.9.3. France Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

?
12. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC HUMAN MICROBIOME MARKET OVERVIEW
12.2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
12.5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

12.7. JAPAN MARKET OVERVIEW
12.7.1. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.2. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.7.3. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.2. China Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.8.3. China Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.2. India Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.9.3. India Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

13. MIDDLE EAST AND AFRICA (MEA) HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.4. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
13.5. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.6. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

13.7. SOUTH AFRICA MARKET OVERVIEW
13.7.1. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.7.2. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.7.3. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.8. SAUDI ARABIA MARKET OVERVIEW
13.8.1. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.8.2. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.8.3. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.9. UAE MARKET OVERVIEW
13.9.1. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.9.2. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.9.3. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

14. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

14.7. BRAZIL MARKET OVERVIEW
14.7.1. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.7.2. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
14.7.3. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions

16. HUMAN MICROBIOME MARKET, KEY COMPANY PROFILES
16.1. ENTEROME
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. Product Pipeline
16.1.6. SWOT Analysis
16.1.7. Key Developments
16.2. MERCK & CO., INC.
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. Product Pipeline
16.2.6. SWOT Analysis
16.2.7. Key Developments
16.3. MICROBIOME THERAPEUTICS, LLC
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. Product Pipeline
16.3.6. SWOT Analysis
16.3.7. Key Developments
16.4. REBIOTIX INC.
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. Product Pipeline
16.4.6. SWOT Analysis
16.4.7. Key Developments
16.5. YAKULT HONSHA CO., LTD.
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. Product Pipeline
16.5.6. SWOT Analysis
16.5.7. Key Developments
16.6. OSEL INC.
16.6.1. Business Description
16.6.2. Financial Overview
16.6.3. Product Portfolio
16.6.4. Product Pipeline
16.6.5. SWOT Analysis
16.6.6. Key Developments
16.7. Vedanta Biosciences, Inc.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. Product Pipeline
16.7.6. SWOT Analysis
16.7.7. Key Developments
16.8. Metabiomics Corporate
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. Product Pipeline
16.8.6. SWOT Analysis
16.8.7. Key Developments
16.9. Synthetic Biologics, Inc.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. Product Pipeline
16.9.6. SWOT Analysis
16.9.7. Key Developments
16.10. DUPONT
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. Product Pipeline
16.10.6. SWOT Analysis
16.10.7. Key Developments

17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies

1. ENTEROME
2. Merck & Co., Inc.
3. MICROBIOME THERAPEUTICS, LLC
4. Rebiotix Inc.
5. Yakult Honsha Co., Ltd.
6. Osel Inc.
7. Vedanta Biosciences, Inc.
8. Metabiomics Corporate
9. Synthetic Biologics, Inc.
10. DUPONT

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book